Illumina

Field Applications Scientist

Bogota, D.C., Bogota, D.C., Colombia

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, GenomicsIndustries

Requirements

Candidates must be fluent in English, possessing a Bachelor's degree in a scientific field such as Biology, Biochemistry, or a related discipline. A strong understanding of library preparation techniques and Next-Generation Sequencing (NGS) is desirable, along with experience in the LATAM EM region.

Responsibilities

The Field Applications Scientist will provide remote second-level field applications support to customers and channel partners, documenting interactions in SFDC and responding to inquiries. They will develop and edit technical documentation and training materials, participate in ongoing product training, and assist the commercial team on sales calls with technical assistance. The role involves applying problem-solving techniques to resolve routine issues, determining a course of action based on established procedures, and working on assignments of limited scope with guided leadership.

Skills

English Fluency

Library preparation

NGS

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free